TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 6567953

Group type: EXPERIMENTAL
Intervention: Preadmission program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Program given the eve of surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 31578023

Group type: EXPERIMENTAL
Intervention: OIT with low allergen cookies (LACs)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 29463627

Group type: EXPERIMENTAL
Intervention: Spironolactone (12.5-50 mg QD)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Clonidine (0.1-0.3 mg BID)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 187

Group type: COMPARATOR
Intervention: Clonidine
Number of subjects: 187
Study: 28078857

Group type: EXPERIMENTAL
Intervention: Sevoflurane (1% administered immediately after the beginning of cardiopulmonary bypass until the end of treatment)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (oxygen mask and physiological saline)
Number of subjects: 60
Study: 24375465

Group type: EXPERIMENTAL
Intervention: Defusion protocol (DEF)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Motivational protocol (MOT)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (CMOT)
Number of subjects: 23
Study: 22424006

Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Developer-reported ECG analysis
Number of subjects: 181

Group type: COMPARATOR
Intervention: Sponsor-reported ECG analysis
Number of subjects: 181
Study: 20136971

Group type: EXPERIMENTAL
Intervention: Routine second-look endoscopy with thermal coagulation
Number of subjects: 998

Group type: COMPARATOR
Intervention: Single endoscopy
Number of subjects: 998

Group type: EXPERIMENTAL
Intervention: Endoscopic injection therapy
Number of subjects: 998
Study: 17928750

Group type: EXPERIMENTAL
Intervention: Duodenoscopic infusion of 90 mL of sodium phosphate (NaP) diluted with 180 mL of water (group EA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Orally administered 45 mL of sodium phosphate (NaP) (group OA)
Number of subjects: 0
Study: 15603570

Group type: EXPERIMENTAL
Intervention: Episiotomy only for fetal indications
Number of subjects: 146

Group type: COMPARATOR
Intervention: Episiotomy at a tear presumed to be imminent
Number of subjects: 146
Study: 12222651

Group type: EXPERIMENTAL
Intervention: Stabilization splint
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control splint
Number of subjects: 36
Study: 10915398

Group type: EXPERIMENTAL
Intervention: two 160-mg capsules once daily (OD)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: one 160-mg capsule twice daily (BID)
Number of subjects: 100
Study: 8605792

Group type: EXPERIMENTAL
Intervention: Lorazepam (intermittent intravenous injection, 1.6 +/- 0.1 mg/8 hrs)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Midazolam (continuous intravenous infusion, 14.4 +/- 1.2 mg/8 hrs)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 95

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 95
Study: 1845581

Group type: EXPERIMENTAL
Intervention: Brief counselling and a booklet
Number of subjects: 156

Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 156
Study: 6123806

Group type: EXPERIMENTAL
Intervention: Cyclosporin A (CyA)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Azathioprine and steroids (control)
Number of subjects: 232
Study: 30481329

Group type: EXPERIMENTAL
Intervention: Longer sleep onset latency (SOL)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Greater sensory pain
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 42
Study: 30381319

Group type: EXPERIMENTAL
Intervention: Sexual rehabilitation (12 weeks of physical exercise training, pelvic floor exercise, and psychoeducation)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 154
Study: 27871846

Group type: COMPARATOR
Intervention: Recovery at room temperature (20 °C)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Ice-water immersion (3 °C, 5 min)
Number of subjects: 11
Study: 27021566

Group type: EXPERIMENTAL
Intervention: Perindopril
Number of subjects: 8726

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8726
Study: 24594903

Group type: EXPERIMENTAL
Intervention: Ad libitum smoking followed by four days of biochemically verified smoking abstinence
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Follicular phase
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Luteal phase
Number of subjects: 147
Study: 22459892

Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 9253

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9253
Study: 19921223

Group type: EXPERIMENTAL
Intervention: MPE (multimodal preoperative evaluation)
Number of subjects: 225
Study: 17552048

Group type: EXPERIMENTAL
Intervention: Infliximab plus MTX (3 mg/kg)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Infliximab plus MTX (6 mg/kg)
Number of subjects: 144

Group type: COMPARATOR
Intervention: MTX alone
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Infliximab plus MTX (3 mg/kg) and (6 mg/kg)
Number of subjects: 144
Study: 15726847

Group type: EXPERIMENTAL
Intervention: ITI implants
Number of subjects: 28

Group type: COMPARATOR
Intervention: Brånemark implants
Number of subjects: 28
Study: 12498856

Group type: EXPERIMENTAL
Intervention: Topical apraclonidine 1%
Number of subjects: 61

Group type: COMPARATOR
Intervention: Artificial tears (control)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Comparison of apraclonidine vs control
Number of subjects: 61
Study: 9611008

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with a combination of cis‐diamminedichloroplatinum (CDDP), vincristine, mitomycin C, and peplomycin (POMP)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Adjuvant radiotherapy
Number of subjects: 101
Study: 7704391

Group type: EXPERIMENTAL
Intervention: Cephalometric indices in OSAS patients
Number of subjects: 16

Group type: COMPARATOR
Intervention: Cephalometric indices in controls
Number of subjects: 16
Study: 1823658

Group type: EXPERIMENTAL
Intervention: Dental fear treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Attention effects (waiting list control)
Number of subjects: 60
Study: 6160901

Group type: EXPERIMENTAL
Intervention: Glucagon
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 31835514

Group type: EXPERIMENTAL
Intervention: Simulated chess games (computer)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Real chess games
Number of subjects: 27
Study: 28697226

Group type: EXPERIMENTAL
Intervention: Topical proprietary procedural enhancement system (PES) containing a combination of active ingredients including a tripeptide and hexapeptide (TriHex Technology™)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Basic regimen (Aquaphor™, Cerave™ cleanser, Vanicream™, Alastin Broad Spectrum 30+ Sunscreen)
Number of subjects: 0
Study: 25887378

Group type: EXPERIMENTAL
Intervention: Shared Decision Making (SDM) programme
Number of subjects: 306

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 306
Study: 24131606

Group type: EXPERIMENTAL
Intervention: Ponto Pro's omnidirectional microphone (OM)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Ponto Pro's split directional microphone (SDM)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Ponto Pro's full directional microphone (FDM)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Ponto Pro
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Ponto Pro's OM
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Ponto Pro's SDM
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Ponto Pro's FDM
Number of subjects: 15
Study: 21259031

Group type: EXPERIMENTAL
Intervention: Intravenous amoxicillin and clavulanic acid (single dose)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Normal saline placebo (equal volume, intravenous bolus)
Number of subjects: 98
Study: 19752483

Group type: EXPERIMENTAL
Intervention: Isoflurane anesthesia
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Desflurane anesthesia
Number of subjects: 108
Study: 17207671

Group type: EXPERIMENTAL
Intervention: Loaded sit-to-stand (STS) resistance exercise 3 times a week for 6 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Regular physical therapy
Number of subjects: 20
Study: 15121054

Group type: EXPERIMENTAL
Intervention: Normal males (G1) with strong spectral pattern and high complexity
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Normal males (G2) with weak spectral pattern and low complexity
Number of subjects: 119

Group type: COMPARATOR
Intervention: Larynx cancer cases (post-irradiation)
Number of subjects: 119
Study: 11549680

Group type: EXPERIMENTAL
Intervention: Glucagon-like peptide-1 (7-36) amide infusion
Number of subjects: 115
Study: 9702436

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional insulin treatment (CIT)
Number of subjects: 30
Study: 7977878

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 64

Group type: COMPARATOR
Intervention: Nortriptyline
Number of subjects: 64
Study: 2610663

Group type: EXPERIMENTAL
Intervention: Alcohol (0.85 g/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 337865

Group type: EXPERIMENTAL
Intervention: Isoniazid
Number of subjects: 25000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25000
Study: 31102331

Group type: EXPERIMENTAL
Intervention: Mindray BC‐6800 hematology analyzer
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Discriminative scoring system (SS) based on automated BM counts
Number of subjects: 101

Group type: COMPARATOR
Intervention: Comparison set using Advia 2120 and CELL‐DYN Sapphire analyzers
Number of subjects: 101
Study: 28503739

Group type: EXPERIMENTAL
Intervention: Interdental brushes (Group A)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Dental floss (Group C)
Number of subjects: 108

Group type: COMPARATOR
Intervention: No interdental hygiene (Group B)
Number of subjects: 108
Study: 26314489

Group type: EXPERIMENTAL
Intervention: Modified Valsalva manoeuvre (semi‐recumbent with supine repositioning and passive leg raise immediately after the Valsalva strain)
Number of subjects: 433

Group type: COMPARATOR
Intervention: Standard semi‐recumbent Valsalva manoeuvre
Number of subjects: 433
Study: 23243254

Group type: COMPARATOR
Intervention: Vitamin E (10 mg•kg(‐1) of feed; VE‐10)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Vitamin E (100 mg•kg(‐1) of feed; VE‐100)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Oregano essential oil (100 mg•kg(‐1) of feed; OR‐100)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Honey (3%) added to meat
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Butylated hydroxytoluene (0.02%; BHT) added to meat
Number of subjects: 60
Study: 21411715

Group type: EXPERIMENTAL
Intervention: Real repetitive lumbosacral magnetic stimulation (rLMS; 15 Hz with a total of 1500 pulses/session) for 10 sessions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham repetitive lumbosacral magnetic stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Real repetitive lumbosacral magnetic stimulation (rLMS)
Number of subjects: 0
Study: 19336657

Group type: EXPERIMENTAL
Intervention: Insulin glulisine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular insulin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin aspart
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin lispro
Number of subjects: 0
Study: 17237494

Group type: EXPERIMENTAL
Intervention: Academic detailing (AD) method
Number of subjects: 819777

Group type: EXPERIMENTAL
Intervention: Problem‐based learning (PBL) method
Number of subjects: 819777

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 819777
Study: 15172395

Group type: EXPERIMENTAL
Intervention: On-site primary angioplasty (PA)
Number of subjects: 571

Group type: COMPARATOR
Intervention: Transfer for primary angioplasty (PA)
Number of subjects: 571
Study: 11289700

Group type: EXPERIMENTAL
Intervention: Propylthiouracil (PTU) 3 x 100 mg/d for 30 d
Number of subjects: 27

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 27
Study: 9124328

Group type: EXPERIMENTAL
Intervention: LOW
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: LOW+BCAA
Number of subjects: 6

Group type: COMPARATOR
Intervention: CON
Number of subjects: 6
Study: 7946585

Group type: EXPERIMENTAL
Intervention: Methotrexate plus lonidamine (MTX + LND)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Methotrexate alone (MTX)
Number of subjects: 89
Study: 3607818

Group type: EXPERIMENTAL
Intervention: Pyrethrin-piperonyl-butoxide shampoo
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pyrethrin-piperonyl-butoxide lotion
Number of subjects: 40
Study: 29289531

Group type: EXPERIMENTAL
Intervention: GSR biofeedback therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 40
Study: 26551986

Group type: EXPERIMENTAL
Intervention: Statin arm (atorvastatin 80 mg/10 mg or simvastatin 20 mg)
Number of subjects: 13937
Study: 25615992

Group type: EXPERIMENTAL
Intervention: Quiz game format
Number of subjects: 66

Group type: COMPARATOR
Intervention: Didactic lecture format
Number of subjects: 66
Study: 23994935

Group type: EXPERIMENTAL
Intervention: Melatonin (melaxen)
Number of subjects: 30
Study: 20934571

Group type: EXPERIMENTAL
Intervention: Any hospital admission
Number of subjects: 933
Study: 18847464

Group type: EXPERIMENTAL
Intervention: Turkish version of the adapted leaflet
Number of subjects: 57

Group type: COMPARATOR
Intervention: Original German leaflet
Number of subjects: 57
Study: 16618298

Group type: EXPERIMENTAL
Intervention: Fresh autologous whole blood (15 ml x kg(‐1) collected prior to heparinization)
Number of subjects: 32

Group type: COMPARATOR
Intervention: 5% albumin (15 ml x kg(‐1) infused intravenously)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Fresh autologous whole blood
Number of subjects: 32
Study: 12746768

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 896

Group type: COMPARATOR
Intervention: Clarithromycin
Number of subjects: 896
Study: 10764420

Group type: EXPERIMENTAL
Intervention: RT + CT
Number of subjects: 243

Group type: COMPARATOR
Intervention: RT
Number of subjects: 243
Study: 8823596

Group type: EXPERIMENTAL
Intervention: 1% cyclopentolate
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 1% tropicamide
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 2.5% phenylephrine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 1% cyclopentolate and 1% tropicamide
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 2.5% phenylephrine and 1% tropicamide
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 0.5% cyclopentolate, 0.5% tropicamide and 2.5% phenylephrine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 1% cyclopentolate and 2.5% phenylephrine
Number of subjects: 80

Group type: COMPARATOR
Intervention: 0.9% NaCl
Number of subjects: 80
Study: 1483442

Group type: EXPERIMENTAL
Intervention: Obese group
Number of subjects: 23

Group type: COMPARATOR
Intervention: Nonobese group
Number of subjects: 23
Study: 4016054

Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Combination of hyaluronate plus systemic acetazolamide
Number of subjects: 26

Group type: COMPARATOR
Intervention: Air
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 26
Study: 31096123

Group type: EXPERIMENTAL
Intervention: Sleep extension (EXT)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Sleep extension (EXT) after resuming habitual sleep
Number of subjects: 50
Study: 29143484

Group type: EXPERIMENTAL
Intervention: 400 μg d‐1 folate after 4 weeks
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: 800 μg d‐1 folate after 4 weeks
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: 400 μg d‐1 folate after 8 weeks
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: 800 μg d‐1 folate after 8 weeks
Number of subjects: 119
Study: 26381715

Group type: EXPERIMENTAL
Intervention: Group II (mildly pre-eclamptic mothers' fetuses)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Group III (severe pre-eclamptic mothers' fetuses)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Group I (healthy mothers' fetuses)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 73
Study: 25354015

Group type: EXPERIMENTAL
Intervention: Daily online tube potential‐cone beam CT (CBCT) image guidance with reduced CTV2 to PTV2 margins (3 mm)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard 5-mm CTV2 to PTV2 margin
Number of subjects: 18
Study: 22167005

Group type: EXPERIMENTAL
Intervention: Pure transvaginal appendectomy (TVA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional laparoscopic appendectomy (LA)
Number of subjects: 40
Study: 20460360

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (8 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 17880774

Group type: EXPERIMENTAL
Intervention: Thiamphenicol glycinate acetylcisteinate (TGA) 500 mg b.i.d. intramuscularly on the first day and TGA 500 mg b.i.d. by aerosol during the following days (n=151)
Number of subjects: 817

Group type: EXPERIMENTAL
Intervention: Thiamphenicol glycinate acetylcisteinate (TGA) 250 mg b.i.d. by aerosol (n=149)
Number of subjects: 817

Group type: COMPARATOR
Intervention: Other standard antibiotics given intramuscularly (n=268)
Number of subjects: 817

Group type: COMPARATOR
Intervention: Other standard antibiotics given orally (n=249)
Number of subjects: 817

Group type: EXPERIMENTAL
Intervention: Thiamphenicol glycinate acetylcisteinate (TGA)
Number of subjects: 817
Study: 16627794

Group type: EXPERIMENTAL
Intervention: Active treatment (perindopril for all, plus indapamide for some)
Number of subjects: 6105
Study: 14596362

Group type: EXPERIMENTAL
Intervention: Candesartan 8/16mg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 12.5 mg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Candesartan 8/16mg and Hydrochlorothiazide 12.5 mg (combination)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 10953904

Group type: EXPERIMENTAL
Intervention: Instruction (limb position instructions)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Auditory cue (listen to impact sounds)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Imagery (metaphorical)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control
Number of subjects: 80
Study: 8612863

Group type: EXPERIMENTAL
Intervention: Cryopreservation of all embryos (n = 13)
Number of subjects: 26

Group type: COMPARATOR
Intervention: IV infusions of albumin (n = 13)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Cryopreservation of all embryos
Number of subjects: 26

Group type: COMPARATOR
Intervention: IV infusions of albumin
Number of subjects: 26
Study: 1295286

Group type: EXPERIMENTAL
Intervention: Pinaverium bromide (50 mg, two tablets)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 6540581

Group type: EXPERIMENTAL
Intervention: Nisoldipine (10 mg orally)
Number of subjects: 18
Study: 30724746

Group type: EXPERIMENTAL
Intervention: New incontinence containment product
Number of subjects: 12

Group type: COMPARATOR
Intervention: Premium adult diaper (control)
Number of subjects: 12
Study: 27341088

Group type: EXPERIMENTAL
Intervention: Plyometric warm-up and high-intensity plyometric protocol
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (CONT)
Number of subjects: 32
Study: 26012640

Group type: EXPERIMENTAL
Intervention: Top tertile of soluble CD40L levels
Number of subjects: 3044

Group type: EXPERIMENTAL
Intervention: Elevated levels of sCD40L and high-sensitive C-reactive protein
Number of subjects: 3044
Study: 24595306

Group type: EXPERIMENTAL
Intervention: HIGH exercise trial (30 min at 60% Wmax)
Number of subjects: 8

Group type: COMPARATOR
Intervention: LOW exercise trial (60 min at 30% Wmax)
Number of subjects: 8
Study: 22525955

Group type: EXPERIMENTAL
Intervention: Joint attention intervention group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Symbolic play intervention group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Baseline play diversity
Number of subjects: 40
Study: 19950090

Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg orally for the first four days
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg orally from the fifth to the eighth day
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Pantoprazole
Number of subjects: 31
Study: 17543743

Group type: EXPERIMENTAL
Intervention: Thrombectomy
Number of subjects: 215

Group type: COMPARATOR
Intervention: Control group (primary percutaneous coronary intervention without thrombectomy)
Number of subjects: 215
Study: 15093878

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 2289

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2289
Study: 11251731

Group type: EXPERIMENTAL
Intervention: Reiki Touch therapy
Number of subjects: 23
Study: 9444543

Group type: EXPERIMENTAL
Intervention: Fluoxetine (8-week treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (8-week treatment)
Number of subjects: 0
Study: 7936522

Group type: EXPERIMENTAL
Intervention: Early discharge with nurse specialist home follow-up care
Number of subjects: 122

Group type: COMPARATOR
Intervention: Usual discharge care
Number of subjects: 122
Study: 3315602

Group type: EXPERIMENTAL
Intervention: Anisoylated plasminogen streptokinase activator complex (APSAC; 30U)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Intracoronary streptokinase (250,000U)
Number of subjects: 54
Study: 30249337

Group type: EXPERIMENTAL
Intervention: Threat condition
Number of subjects: 102

Group type: COMPARATOR
Intervention: No-threat condition
Number of subjects: 102
Study: 25854771

Group type: EXPERIMENTAL
Intervention: Static Stretching (SS)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cyclic Stretching (CS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study: 25619549

Group type: EXPERIMENTAL
Intervention: Initiation of an oral loop diuretic at discharge
Number of subjects: 6119

Group type: COMPARATOR
Intervention: Change in loop diuretic dose at discharge for patients already established on diuretics prior to admission
Number of subjects: 6119